Related posts
Weekly 52-Week Low (or 52-Week High): AC-T, EMA-T, BTE-T, LIO-X and More 52-Week Highs and Lows (Dec 04-10)Most Anticipated Earnings: IAG-T, BDT-T and more Canadian Companies Reporting Earnings this Week (Nov 04-08)Stocks largely flatThis summary was created by AI, based on 17 opinions in the last 12 months.
The experts seem to have mixed opinions about WELL Health Technologies. While some appreciate the management team and its acquisitions, others are concerned about the valuation and lack of profitability. The company has shown growth potential and a focus on digital health, but there are also reservations about its high valuation and volatility. Overall, there is a sense of cautious optimism about the stock, with a focus on watching for potential catalysts and growth.
Has a lid on it going back 3 years. There is no right or wrong answer, but when you're coming into an old resistance point, you have to have a catalyst to get through. Remember, people sold (didn't like) this stock at that peak level (around $5.50). And now it's approaching that level.
If there's a catalyst to break through, it will, but keep in mind that it has to be a pretty big catalyst. If there's not a huge change to the company, he'd probably look to sell really soon.
It is a really interesting mid cap of about $1 billion. It is very well managed and has made a couple of really strong acquisitions. It has increased its margins and revenue and upped its guidance last week. It is also profitable and the growth rate looks really good but the stock has lagged. Management has never strayed from their strategy and is going to grow this business and shift the Canadian market into the digitalized type of world.
Too small for his portfolios. In Canada, rolling up medical practices with a strategy of using technology to reduce administrative burden. In US, has a GI line, as well as virtual mental health and women's care; may spin off the latter two. Valuation ~40x forward PE, rich. He can't get behind that valuation, but progress will be interesting to watch.
Has looked at in the past, but believes stock has always been over valued. Trend is towards digital health, but not investing at this time. Will continue to watch. If margins increase, might invest.
Looks as though it wants to push higher and retest recent highs from 2023. Looks good, let it run. Thinks there's more upside.
In different areas of the market. Healthcare tends to be a more regulated industry, so he doesn't have a strong opinion. Scale has a role to play. Its businesses don't have the makings of huge homeruns. Neutral.
Management team has solid record of success. Continues to make acquisitions and grow company. Caught on during Covid, valuation probably got stretched; now backfilling the valuation. Fairly attractive right now. He's watching for them to move margins up.
This is an example of buying a mispriced stock at low prices. Markets are not efficient and get things wrong all the time. WELL had a good Q2 with strong organic growth - 98% returning revenue and 37% revenue growth. It still has to grow into itself since it is very expensive, trading at 100X 2025, but if the growth comes through it is 10X by 2026. Therefore it needs to execute.
Lots of momentum in the US. 12-month price target of $6.47.
Company ability to grow very good. Lately stock has been volatile. M&A a little questionable. Has not been following business closely. Good option in the healthcare space, but would recommend watching.
Small cap. It would move with a major catalyst like institutional interest, a major contract, or a merger. Otherwise, it's just not on the radar. People own these hoping for a home run, but have to look at your opportunity cost.
Increased 2024 guidance. 98% recurring revenue which is very attractive. Not a cheap valuation, would recommend holding, or buying on weakness. A good "small position" in portfolio.
It is a digital health company. The CEO ran a previous company which did very well. Well Health did well during Covid and made a lot of acquisitions, but hasn't done well since Covid. He is not interested because of lack of profitability and ROC is not as high as he is looking for. He respects the company which has done a good job on the topline but needs a better bottom line. Analysts seem to like it since they make lots of money from it.
Healthcare is a good theme and the sector needs to be more efficient so opportunities lie ahead. Strongly likes this.
WELL Health Technologies is a Canadian stock, trading under the symbol WELL-T on the Toronto Stock Exchange (WELL-CT). It is usually referred to as TSX:WELL or WELL-T
In the last year, 12 stock analysts published opinions about WELL-T. 6 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for WELL Health Technologies.
WELL Health Technologies was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for WELL Health Technologies.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
12 stock analysts on Stockchase covered WELL Health Technologies In the last year. It is a trending stock that is worth watching.
On 2024-12-13, WELL Health Technologies (WELL-T) stock closed at a price of $6.79.
Great management team. Recent spinoff is interesting, as it's about optimizing value for shareholders, not about empire-building. Capital discipline is there.